4D pharma is a world leader in the development of Live Biotherapeutics, emerging class of drugs, defined by FDA as biological products that have live organism, such as a bacterium, that is the prevention, treatment or cure of a disease.
| Industry: | Health Care |
| Sector: | Health Care |
| Website: | www.4dpharmaplc.com |
| Twitter: | @4dpharmaplc |
| Exchange: | LSE |
| Admission date: | 18 Feb 2014 |
| Market: | Aim |
| Region: | Europe |
| 1 Apr 2022 | Final Results |
| 12 Nov 2022 | Annual Meeting |
| 8 Nov 2022 | Annual Meeting |
| 23 Mar 2022 | Conference Call |